{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:19:40Z","timestamp":1783340380739,"version":"3.54.6"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260598"],"award-info":[{"award-number":["82260598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi Provincial Academic and Technical Leader Training Program in Major Disciplines","award":["20225BCJ22009"],"award-info":[{"award-number":["20225BCJ22009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06595-8","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:42:09Z","timestamp":1783338129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpretable machine learning model of contrast-enhanced CT radiomics for predicting post-BCG recurrence in high-grade non-muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"44","author":[{"given":"Xin Chang","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan Jiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Yang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Chao","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian Jun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"6","key":"6595_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M et al (2022) Epidemiology, Screening, and Prevention of Bladder Cancer. Eur Urol Oncol 5(6):628\u2013639. https:\/\/doi.org\/10.1016\/j.euo.2022.10.003","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"6595_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG et al (2023) Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol 20(5):287\u2013304. https:\/\/doi.org\/10.1038\/s41571-023-00744-3","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6595_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O et al (2022) European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol 81(1):75\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2021.08.010","journal-title":"Eur Urol"},{"issue":"19","key":"6595_CR4","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K et al (2020) Bladder Cancer: A Review. JAMA 324(19):1980\u20131991. https:\/\/doi.org\/10.1001\/jama.2020.17598","journal-title":"JAMA"},{"issue":"2","key":"6595_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.euf.2021.03.016","volume":"8","author":"E Laukhtina","year":"2022","unstructured":"Laukhtina E, Abufaraj M, Al-Ani A et al (2022) Intravesical therapy in patients with intermediate-risk non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of disease recurrence. Eur Urol Focus 8(2):447\u2013456. https:\/\/doi.org\/10.1016\/j.euf.2021.03.016","journal-title":"Eur Urol Focus"},{"key":"6595_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2025.03.007","author":"M Longoni","year":"2025","unstructured":"Longoni M, Scilipoti P, Soria F et al (2025) Oncological outcomes in bacillus calmette-gu\u00e9rin-na\u00efve high-risk non-muscle-invasive bladder cancer patients: a systematic review on current treatment strategies and future perspectives. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euo.2025.03.007","journal-title":"Eur Urol Oncol"},{"key":"6595_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/17562872221109020","volume":"14","author":"M Ferro","year":"2022","unstructured":"Ferro M, de Cobelli O, Musi G et al (2022) Radiomics in prostate cancer: an up-to-date review. Ther Adv Urol 14:17562872221109020. https:\/\/doi.org\/10.1177\/17562872221109020","journal-title":"Ther Adv Urol"},{"key":"6595_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2021.02.010","volume":"505","author":"S Liu","year":"2021","unstructured":"Liu S, Chen X, Lin T (2021) Lymphatic metastasis of bladder cancer: Molecular mechanisms, diagnosis and targeted therapy. Cancer Lett 505:13\u201323. https:\/\/doi.org\/10.1016\/j.canlet.2021.02.010","journal-title":"Cancer Lett"},{"issue":"5","key":"6595_CR9","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1148\/rg.2017170056","volume":"37","author":"MG Lubner","year":"2017","unstructured":"Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ (2017) CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. Radiographics 37(5):1483\u20131503. https:\/\/doi.org\/10.1148\/rg.2017170056","journal-title":"Radiographics"},{"key":"6595_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2025.06.056","author":"Z Yang","year":"2025","unstructured":"Yang Z, Jiang H, Shan S et al (2025) 2.5D deep learning-based prediction of pathological grading of clear cell renal cell carcinoma using contrast-enhanced CT: a multicenter study. Acad Radiol. https:\/\/doi.org\/10.1016\/j.acra.2025.06.056","journal-title":"Acad Radiol"},{"issue":"1143","key":"6595_CR11","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20220238","volume":"96","author":"X Shu","year":"2023","unstructured":"Shu X, Liu Y, Qiao X et al (2023) Radiomic-based machine learning model for the accurate prediction of prostate cancer risk stratification. Br J Radiol 96(1143):20220238. https:\/\/doi.org\/10.1259\/bjr.20220238","journal-title":"Br J Radiol"},{"issue":"1","key":"6595_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40644-023-00609-z","volume":"23","author":"H Song","year":"2023","unstructured":"Song H, Yang S, Yu B et al (2023) CT-based deep learning radiomics nomogram for the prediction of pathological grade in bladder cancer: a multicenter study. Cancer Imaging 23(1):89. https:\/\/doi.org\/10.1186\/s40644-023-00609-z","journal-title":"Cancer Imaging"},{"issue":"1","key":"6595_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13244-023-01569-5","volume":"15","author":"R Sun","year":"2024","unstructured":"Sun R, Zhang M, Yang L et al (2024) Preoperative CT-based deep learning radiomics model to predict lymph node metastasis and patient prognosis in bladder cancer: a two-center study. Insights Imaging 15(1):21. https:\/\/doi.org\/10.1186\/s13244-023-01569-5","journal-title":"Insights Imaging"},{"issue":"1","key":"6595_CR14","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/JS9.0000000000001999","volume":"111","author":"K Chen","year":"2025","unstructured":"Chen K, Li X, Liu L et al (2025) Correlation of noninvasive imaging of tumour-infiltrating lymphocytes with survival and BCG immunotherapy response in patients with bladder cancer: a multicentre cohort study. Int J Surg 111(1):920\u2013931. https:\/\/doi.org\/10.1097\/JS9.0000000000001999","journal-title":"Int J Surg"},{"issue":"3","key":"6595_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/medicina57030220","volume":"57","author":"RT Abouelkheir","year":"2021","unstructured":"Abouelkheir RT, Abdelhamid A, Abou El-Ghar M et al (2021) Imaging of bladder cancer: standard applications and future trends. Medicina (Kaunas) 57(3):220. https:\/\/doi.org\/10.3390\/medicina57030220","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"6595_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","volume":"39","author":"K Ng","year":"2021","unstructured":"Ng K, Stenzl A, Sharma A et al (2021) Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Urol Oncol 39(1):41\u201351. https:\/\/doi.org\/10.1016\/j.urolonc.2020.08.016","journal-title":"Urol Oncol"},{"issue":"3","key":"6595_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/iju.15338","volume":"31","author":"E Tomiyama","year":"2024","unstructured":"Tomiyama E, Fujita K, Hashimoto M et al (2024) Urinary markers for bladder cancer diagnosis: A review of current status and future challenges. Int J Urol 31(3):208\u2013219. https:\/\/doi.org\/10.1111\/iju.15338","journal-title":"Int J Urol"},{"issue":"1","key":"6595_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s12935-021-02169-3","volume":"21","author":"D Shang","year":"2021","unstructured":"Shang D, Liu Y, Xu X et al (2021) Diagnostic value comparison of CellDetect, fluorescent in situ hybridization (FISH), and cytology in urothelial carcinoma. Cancer Cell Int 21(1):465. https:\/\/doi.org\/10.1186\/s12935-021-02169-3","journal-title":"Cancer Cell Int"},{"issue":"3","key":"6595_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.urolonc.2020.11.014","volume":"39","author":"JRE Wolfs","year":"2021","unstructured":"Wolfs JRE, Hermans TJN, Koldewijn EL et al (2021) Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: A review. Urol Oncol 39(3):161\u2013170. https:\/\/doi.org\/10.1016\/j.urolonc.2020.11.014","journal-title":"Urol Oncol"},{"issue":"1","key":"6595_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.21037\/tau.2019.01.15","volume":"8","author":"S Zamboni","year":"2019","unstructured":"Zamboni S, Moschini M, Simeone C et al (2019) Prediction tools in non-muscle invasive bladder cancer. Transl Androl Urol 8(1):39\u201345. https:\/\/doi.org\/10.21037\/tau.2019.01.15","journal-title":"Transl Androl Urol"},{"issue":"3","key":"6595_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.euf.2018.11.005","volume":"6","author":"V Soukup","year":"2020","unstructured":"Soukup V, \u010capoun O, Cohen D et al (2020) Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel. Eur Urol Focus 6(3):479\u2013489. https:\/\/doi.org\/10.1016\/j.euf.2018.11.005","journal-title":"Eur Urol Focus"},{"issue":"11","key":"6595_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.urolonc.2022.06.008","volume":"40","author":"W Krajewski","year":"2022","unstructured":"Krajewski W, Aumatell J, Subiela JD et al (2022) Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer. Urol Oncol 40(11):491. https:\/\/doi.org\/10.1016\/j.urolonc.2022.06.008","journal-title":"Urol Oncol"},{"key":"6595_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-026-01153-8","author":"L Cella","year":"2026","unstructured":"Cella L, Lin J, Goldenberg MG, Hung AJ (2026) The future of robotic surgery in the age of artificial intelligence. Nat Rev Urol. https:\/\/doi.org\/10.1038\/s41585-026-01153-8","journal-title":"Nat Rev Urol"},{"key":"6595_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-025-01122-7","author":"H Al-Sattar","year":"2026","unstructured":"Al-Sattar H, Ding H, Okoli O et al (2026) A multi-modal approach for decision making in bladder cancer. Nat Rev Urol. https:\/\/doi.org\/10.1038\/s41585-025-01122-7","journal-title":"Nat Rev Urol"},{"issue":"5","key":"6595_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/14737140.2025.2604617","volume":"26","author":"S Saran Manivasagam","year":"2026","unstructured":"Saran Manivasagam S, Raman JD, Aminsharifi A (2026) Integrating artificial intelligence across the bladder cancer continuum: progress, promise, and pitfalls. Expert Rev Anticancer Ther 26(5):557\u2013567. https:\/\/doi.org\/10.1080\/14737140.2025.2604617","journal-title":"Expert Rev Anticancer Ther"},{"key":"6595_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.615091","volume":"11","author":"CJ Lim","year":"2021","unstructured":"Lim CJ, Nguyen PHD, Wasser M et al (2021) Immunological hallmarks for clinical response to BCG in bladder cancer. Front Immunol 11:615091. https:\/\/doi.org\/10.3389\/fimmu.2020.615091","journal-title":"Front Immunol"},{"issue":"15","key":"6595_CR27","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3390\/cells12151939","volume":"12","author":"D Basak","year":"2023","unstructured":"Basak D, Mondal S, Srivastava SK et al (2023) Intratumoral PD1\u2009+\u2009CD38+Tim3\u2009+\u2009CD8+ T cells in Pre-BCG tumor tissues are associated with poor responsiveness to BCG immunotherapy in patients with non-muscle invasive bladder cancer. Cells 12(15):1939. https:\/\/doi.org\/10.3390\/cells12151939","journal-title":"Cells"},{"key":"6595_CR28","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.2147\/CMAR.S323844","volume":"13","author":"L Zhao","year":"2021","unstructured":"Zhao L, Sun J, Wang K et al (2021) Development of a New Recurrence-Free Survival Prediction Nomogram for Patients with Primary Non-Muscle-Invasive Bladder Cancer Based on Preoperative Controlling Nutritional Status Score. Cancer Manag Res 13:6473\u20136487. https:\/\/doi.org\/10.2147\/CMAR.S323844","journal-title":"Cancer Manag Res"},{"issue":"5","key":"6595_CR29","doi-asserted-by":"publisher","first-page":"256.e9","DOI":"10.1016\/j.urolonc.2023.01.016","volume":"41","author":"J Daza","year":"2023","unstructured":"Daza J, Grauer R, Chen S et al (2023) Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer. Urol Oncol 41(5):256.e9-256.e15. https:\/\/doi.org\/10.1016\/j.urolonc.2023.01.016","journal-title":"Urol Oncol"},{"key":"6595_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1070043","volume":"13","author":"L Ding","year":"2022","unstructured":"Ding L, Deng X, Xia W et al (2022) Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer. Front Immunol 13:1070043. https:\/\/doi.org\/10.3389\/fimmu.2022.1070043","journal-title":"Front Immunol"},{"key":"6595_CR31","doi-asserted-by":"publisher","DOI":"10.1159\/000543112","author":"K Tully","year":"2024","unstructured":"Tully K, Bahlburg H, Reike MJ et al (2024) Discrimination of T-Stage using tumor weight and size: a potential approach to guide perioperative decision-making in patients with bladder cancer. Urol Int 1\u20137. https:\/\/doi.org\/10.1159\/000543112","journal-title":"Urol Int"},{"issue":"5","key":"6595_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10050980","volume":"10","author":"A Morlacco","year":"2021","unstructured":"Morlacco A, Modonutti D, Motterle G et al (2021) Nomograms in urologic oncology: lights and shadows. J Clin Med 10(5):980. https:\/\/doi.org\/10.3390\/jcm10050980","journal-title":"J Clin Med"},{"issue":"1","key":"6595_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semradonc.2022.10.009","volume":"33","author":"NS Moore","year":"2023","unstructured":"Moore NS, McWilliam A, Aneja S (2023) Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence. Semin Radiat Oncol 33(1):70\u201375. https:\/\/doi.org\/10.1016\/j.semradonc.2022.10.009","journal-title":"Semin Radiat Oncol"},{"key":"6595_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/17562872231164803","volume":"15","author":"M Ferro","year":"2023","unstructured":"Ferro M, Crocetto F, Barone B et al (2023) Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review. Ther Adv Urol 15:17562872231164803. https:\/\/doi.org\/10.1177\/17562872231164803","journal-title":"Ther Adv Urol"},{"issue":"5","key":"6595_CR35","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1007\/s00330-021-08426-3","volume":"32","author":"G Zhang","year":"2022","unstructured":"Zhang G, Wu Z, Zhang X et al (2022) CT-based radiomics to predict muscle invasion in bladder cancer. Eur Radiol 32(5):3260\u20133268. https:\/\/doi.org\/10.1007\/s00330-021-08426-3","journal-title":"Eur Radiol"},{"issue":"5","key":"6595_CR36","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1097\/JS9.0000000000001194","volume":"110","author":"Z Wei","year":"2024","unstructured":"Wei Z, Xv Y, Liu H et al (2024) A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study. Int J Surg 110(5):2922\u20132932. https:\/\/doi.org\/10.1097\/JS9.0000000000001194","journal-title":"Int J Surg"},{"issue":"9","key":"6595_CR37","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1002\/mp.17288","volume":"51","author":"S Xiong","year":"2024","unstructured":"Xiong S, Fu Z, Deng Z et al (2024) Machine learning-based CT radiomics enhances bladder cancer staging predictions: A comparative study of clinical, radiomics, and combined models. Med Phys 51(9):5965\u20135977. https:\/\/doi.org\/10.1002\/mp.17288","journal-title":"Med Phys"},{"issue":"3","key":"6595_CR38","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/jmri.29574","volume":"61","author":"H Huang","year":"2025","unstructured":"Huang H, Huang Y, Kaggie JD et al (2025) Multiparametric MRI-Based Deep Learning Radiomics Model for Assessing 5-Year Recurrence Risk in Non-Muscle Invasive Bladder Cancer. J Magn Reson Imaging 61(3):1442\u20131456. https:\/\/doi.org\/10.1002\/jmri.29574","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"6595_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.32604\/or.2023.028163","volume":"31","author":"GM Villoldo","year":"2023","unstructured":"Villoldo GM, Pombo MT, Aris M et al (2023) A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Gu\u00e9rin in patients with non-muscle invasive bladder carcinoma: a retrospective study. Oncol Res 31(2):207\u2013220. https:\/\/doi.org\/10.32604\/or.2023.028163","journal-title":"Oncol Res"},{"issue":"3","key":"6595_CR40","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.euf.2021.05.005","volume":"8","author":"M Kozikowski","year":"2022","unstructured":"Kozikowski M, Suarez-Ibarrola R, Osiecki R et al (2022) Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus 8(3):728\u2013738. https:\/\/doi.org\/10.1016\/j.euf.2021.05.005","journal-title":"Eur Urol Focus"},{"key":"6595_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1509362","volume":"14","author":"S Abbas","year":"2025","unstructured":"Abbas S, Shafik R, Soomro N et al (2025) AI predicting recurrence in non-muscle-invasive bladder cancer: systematic review with study strengths and weaknesses. Front Oncol 14:1509362. https:\/\/doi.org\/10.3389\/fonc.2024.1509362","journal-title":"Front Oncol"},{"issue":"2","key":"6595_CR42","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.acra.2024.09.036","volume":"32","author":"H Li","year":"2025","unstructured":"Li H, Sui Y, Tao Y et al (2025) Coupling Habitat Radiomic Analysis with the Diversification of the Tumor ecosystem: Illuminating New Strategy in the Assessment of Postoperative Recurrence of Non-Muscle Invasive Bladder Cancer. Acad Radiol 32(2):821\u2013833. https:\/\/doi.org\/10.1016\/j.acra.2024.09.036","journal-title":"Acad Radiol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06595-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06595-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06595-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:42:10Z","timestamp":1783338130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06595-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6595"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06595-8","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study and its associated projects have been approved by the Biomedical Research Ethics Committee of the Second Affiliated Hospital of Nanchang University and the Ethics Committee of the First Affiliated Hospital of Nanchang University, with the requirement for informed consent waived by these committees. All procedures were conducted in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have read and agreed to submit this manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"486"}}